CFN Media Group, the digital media network and creative agency dedicated to legal cannabis, reported that it had entered into a three month investor awareness initiative for Medical Marijuana Inc (OTCMKTS:MJNA).
The highlights
Frank Lane, the President of CFN Media, said that they are delighted to be working with a pioneer firm in medical marijuana industry. Medical Marijuana’s progress in introducing its RSHO™ to market across Mexico, Paraguay, Brazil and Puerto Rico demonstrates the management team’s ability to execute and the dedication to assisting patients get access to the medicines they need.
The hemp and cannabis innovator leverages a team of professionals to assess, source and purchase value-added products and companies. They strive to generate awareness within the marketplace, advance environmentally-friendly, viable businesses that enhance shareholder value in coming period.
Stuart Titus, the CEO of Medical Marijuana, expressed that they look forward to new alliance with Cannabis Financial Network. Their team will help the company to better relate their story to investors. Although they are publicly traded and hold a large shareholder base, their focus has been on the development of global markets.
The CEO added that to this point they have not engaged the investors to any great degree. However, the latest development should bring them in focus. It is a fabulous time for the legal hemp and cannabis industry, and with growing increasing investment interest, it appears an excellent time to explicitly articulate their story to the investment group.
CFN Media will use its extensive presence and reach within the legal cannabis industry of the North American together with its content platform to generate investor interest for Medical Marijuana. Prior to this update, the company announced about the receipt of a grant of additional permits for its product RSHO-X™ from the Mexico government. This will help them to expand the firm’s base into a growing market that has a yearly projected worth of $10 billion – 12 billion.
Progressive Care Inc (OTCMKTS:RXMD) Expanding Into New Jersey and Pennsylvania
New Jersey and Pennsylvania have awarded Progressive Care Inc (OTCMKTS:RXMD) non-resident pharmacy licenses that pave the way for the health care service provider to expand its wings in the two states. With the licenses, the company can now dispense its traditional and compounded medications right from its facilities.
The licenses mark yet another milestone achievement for Progressive care, which is aggressively looking for new opportunities for growth. The two states bring to five, the total number of states where the company is currently operating having already touched ground in New York, Texas, and Florida.
Progressive Care Inc (OTCMKTS:RXMD) recently inked a $2million financing agreement that provides it the much-needed working capital to expand its operation in other regions. With the financing, the company can now expand its warehouse space to bolster its handling capacity having posted record revenues on increased drug sales in the month of June.
